Recent Posts
- Children’s Tumor Foundation’s Montse Montaner Joins CureAge Therapeutics
- Children’s Tumor Foundation Featured in Two-Part Series in BioSpace on Reviving Abandoned Drugs for Rare Disease Treatments
- From NF to the World: Rare Disease Day and the Race for Faster Treatments
- Story of NF: Jonah S.
- Healx Announces First Patient Dosed in Phase 2 Trial Evaluating HLX-1502 for the Treatment of NF1
Recent Comments
No comments to show.
